Tozaro

TozaroTozaro
Tozaro

Tozaro

Platform designed to cut cell and gene therapy production costs.

DR 252021Active30London, United Kingdom
Rate

About

Tozaro designs and synthesizes custom affinity ligands, known as smart polymers, for viral vector applications. Their technology blends molecular modeling, machine learning, and chemical synthesis to create tailored ligands for improved viral vector purification and analytics. Tozaro serves the cell and gene therapy manufacturing sector by offering faster, cost-effective ligand production and enhanced bioprocessing capabilities.
Frequently asked

What does Tozaro do?

Tozaro designs and synthesizes custom affinity ligands, known as smart polymers, for viral vector applications. Their technology blends molecular modeling, machine learning, and chemical synthesis to create tailored ligands for improved viral vector purification and analytics. Tozaro serves the cell and gene therapy manufacturing sector by offering faster, cost-effective ligand production and enhanced bioprocessing capabilities.

What is Tozaro's revenue?

StartupHub estimates Tozaro's annual revenue at $4.2M (range $2.4M to $10.9M, 68% confidence), based on comparable companies in the sector.

What is Tozaro's valuation?

StartupHub estimates Tozaro's effective valuation at $28.2M (range $17.3M to $41.4M, 23% confidence), based on comparable companies in the sector.

How much funding has Tozaro raised?

Tozaro has raised a total of $7M in funding. The most recent round on record is Unknown.

Where is Tozaro headquartered?

Tozaro is headquartered in London, England, United Kingdom.

When was Tozaro founded?

Tozaro was founded in 2021.

What industry does Tozaro operate in?

Tozaro operates in Biotechnology, Healthcare, Artificial Intelligence, Life Sciences, Biotech, MedTech.

How many employees does Tozaro have?

Tozaro has approximately 30 people on record.

HEADCOUNT
30
DOMAIN RATING
25
Comments

No comments yet. Be the first to share your take.